Further studies are warranted to provide external validation for anti-DSG2-ab assessment, explore a genotype–phenotype analysis, and to identify the full autoantigenic targets related to the AIDA IFL pattern observed in ARVC and myocarditis. Here, DSG2 is linked to arrhythmogenic right ventricular cardiomyopathy.